Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.
作者信息
Venisse Nicolas
机构信息
INSERM CIC1402, University Hospital of Poitiers, University of Poitiers, Poitiers Cedex, 86021, France.
Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de la Milétrie, Poitiers Cedex, 86021, France.
出版信息
Fundam Clin Pharmacol. 2020 Oct;34(5):528-529. doi: 10.1111/fcp.12588. Epub 2020 Jul 17.
Abstract
摘要
相似文献
1
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.在接受其他治疗的新冠肺炎患者中，目前用于治疗新冠肺炎的药物可能存在的药物相互作用。
Fundam Clin Pharmacol. 2020 Oct;34(5):528-529. doi: 10.1111/fcp.12588. Epub 2020 Jul 17.
2
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.正在接受其他治疗的 COVID-19 患者，在使用目前提议用于 COVID-19 治疗的药物时，可能会发生药物-药物相互作用。
Fundam Clin Pharmacol. 2020 Oct;34(5):530-547. doi: 10.1111/fcp.12586. Epub 2020 Jul 24.
3
Interactions of recommended COVID-19 drugs with commonly used psychotropics.推荐的新冠病毒治疗药物与常用精神药物的相互作用。
Asian J Psychiatr. 2020 Aug;52:102173. doi: 10.1016/j.ajp.2020.102173. Epub 2020 May 21.
4
COVID-19 & antiepileptic drugs: Should we pay attention?新型冠状病毒肺炎与抗癫痫药物：我们应该关注吗？
Seizure. 2020 Aug;80:240-241. doi: 10.1016/j.seizure.2020.07.005. Epub 2020 Jul 7.
5
[Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].[关于法国在新冠疫情期间精神药物及其对精神障碍患者适应性的信息]
Encephale. 2020 Jun;46(3S):S14-S34. doi: 10.1016/j.encep.2020.04.006. Epub 2020 May 4.
6
Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?癌症患者的抗癌药物和 COVID-19 抗病毒治疗：我们可以安全使用哪些药物？
Eur J Cancer. 2020 Sep;136:1-3. doi: 10.1016/j.ejca.2020.05.027. Epub 2020 Jun 10.
7
Psychopharmacology of COVID-19.新型冠状病毒肺炎的精神药理学。
Psychosomatics. 2020 Sep-Oct;61(5):411-427. doi: 10.1016/j.psym.2020.05.006. Epub 2020 May 18.
8
Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.新冠病毒疾病（COVID-19）患者使用羟氯喹的精神科影响
Indian J Pharmacol. 2020 May-Jun;52(3):229-231. doi: 10.4103/ijp.IJP_595_20. Epub 2020 Aug 4.
9
Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir.洛匹那韦/利托那韦治疗的 COVID-19 患者中的潜在药物-药物相互作用。
Med Clin (Barc). 2020 Oct 9;155(7):281-287. doi: 10.1016/j.medcli.2020.06.026. Epub 2020 Jul 9.
10
Guidance on Short-Term Management of Atrial Fibrillation in Coronavirus Disease 2019.《COVID-19 相关心房颤动的短期管理指南》
J Am Heart Assoc. 2020 Jul 21;9(14):e017529. doi: 10.1161/JAHA.120.017529. Epub 2020 Jun 9.
引用本文的文献
1
Tools supporting polypharmacy management in Italy: Factors determining digital technologies' intention to use in clinical practice.意大利支持多药治疗管理的工具：决定数字技术在临床实践中使用意愿的因素。
Health Sci Rep. 2022 May 19;5(3):e647. doi: 10.1002/hsr2.647. eCollection 2022 May.
2
COVID-19 related treatment and outcomes among COVID-19 ICU patients: A retrospective cohort study.COVID-19 相关治疗与 COVID-19 重症监护病房患者结局：一项回顾性队列研究。
J Infect Public Health. 2021 Sep;14(9):1274-1278. doi: 10.1016/j.jiph.2021.08.030. Epub 2021 Aug 28.
本文引用的文献
1
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.正在接受其他治疗的 COVID-19 患者，在使用目前提议用于 COVID-19 治疗的药物时，可能会发生药物-药物相互作用。
Fundam Clin Pharmacol. 2020 Oct;34(5):530-547. doi: 10.1111/fcp.12586. Epub 2020 Jul 24.
2
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.氯喹和羟氯喹在 COVID-19 管理中的应用：喧嚣四起，证据寥寥。
Therapie. 2020 Jul-Aug;75(4):363-370. doi: 10.1016/j.therap.2020.05.010. Epub 2020 May 23.
3
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.启动羟氯喹治疗 COVID-19 感染负荷剂量的理由——DisCoVeRy 试验。
J Antimicrob Chemother. 2020 Sep 1;75(9):2376-2380. doi: 10.1093/jac/dkaa191.
4
Lopinavir pharmacokinetics in COVID-19 patients.洛匹那韦在新冠肺炎患者中的药代动力学。
J Antimicrob Chemother. 2020 Sep 1;75(9):2702-2704. doi: 10.1093/jac/dkaa195.
5
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic.法国药理学和治疗学会在 COVID-19 大流行期间创建应急公共药物信息网站的起源。
Fundam Clin Pharmacol. 2020 Jun;34(3):389-396. doi: 10.1111/fcp.12564.
6
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.移植受者感染 SARS-CoV-2 的药物治疗：治疗药物监测和药物相互作用的考虑因素。
Ther Drug Monit. 2020 Jun;42(3):360-368. doi: 10.1097/FTD.0000000000000761.
Zotero 插件